← All indications
Colonic Neoplasms
Tumors or cancer of the COLON.
Subtype terms (2)
More specific conditions that are subtypes of Colonic Neoplasms in the MeSH hierarchy.
- Colitis-Associated Neoplasms
- Sigmoid Neoplasms
4 drugs (2 approved, 2 experimental)
Drugs by status
Approved for this indication (5)
Phase 4 trials (45)
- tegafur
- midazolam
- irinotecan
- celecoxib
- sevoflurane
- bisacodyl
- glucagon
- doxycycline
- lactobacillus rhamnosus
- dexmedetomidine
- levobupivacaine
- chlorhexidine
- ropivacaine
- hydrocodone
- polyethylene glycol
- cephalexin
- uracil
- octreotide
- droperidol
- mesalamine
- tramadol
- fish oil
- orphenadrine hydrochloride
- leucovorin
- piritramide
- fentanyl
- ertapenem
- morphine
- acetaminophen
- rivaroxaban
- +15 more
Phase 3 trials (62)
- fruquintinib
- edrecolomab
- Thiosulfuric acid
- dexamethasone
- eniluracil
- ipilimumab
- anx-510
- potassium sulfate
- paclitaxel
- pembrolizumab
- sennosides a&b
- magnesium sulfate
- trastuzumab
- carboplatin
- tamoxifen
- nivolumab
- gentamicin
- minocycline
- icosapent ethyl
- avelumab
- ornidazole
- sodium phosphate
- calcium
- estrogen
- dostarlimab
- vatalanib
- progestin
- xelox
- tislelizumab
- cytokine induced killer cells
- +32 more
Phase 2 trials (204)
- lenvatinib
- thalidomide
- modafinil
- toripalimab
- lapatinib
- cannabidiol
- romiplostim
- vegfr2
- fludeoxyglucose f-18
- dronabinol
- enzastaurin
- mitomycin
- nci-4650
- oteracil
- agen1181
- atorvastatin
- Raltitrexed
- oligofructose-enriched inulin
- gevokizumab
- cea car-t cells
- vegfr1
- savolitinib
- ramucirumab
- balstilimab
- foxy-5
- aminolevulinic acid
- gimeracil
- ibi310
- 5,10-methylene-5,6,7,8-tetrahydrofolate
- ly2880070
- +174 more
Phase 1 trials (104)
- medicinal charcoal
- egfrbi armed atc infusions
- nkg2d car-t cell
- selumetinib
- buparlisib
- gi-6301
- bbo-8520
- cpg-oligonucleotide
- dibenzyl trisulphide
- mgd009
- doxorubicin
- ad5-hgcc-padre vaccine
- Imetelstat
- asn007
- v935
- taladegib
- calcium carbonate
- 18f-fmau
- trk-950
- resveratrol
- tetrahydrocannabinol
- phn-012
- aquamin
- omalizumab
- hbi-2438
- odm-203
- vmd-928
- np-g2-044
- bi 1701963
- qrh-882260
- +74 more
Other trials (53)
- glucose monohydrate
- Poloxalene
- tacrine
- iodine
- dipeptide alanyl-glutamine
- isoflurane
- indocyanine green
- ribavirin
- vitamin e
- kb109
- [68ga]ga-dota-h2d3
- autologous microbiome
- [68ga]ga-nota-rnd20
- Lactobacillus acidophilus
- human peritoneal membrane
- bevacizumab-irdye800cw
- l-cystine
- decitabine
- [18f]f-resca-rb14
- pyrvinium
- nefopam
- [68ga]ga-nota-wwh347
- ramosetron
- formyltetrahydrofolate
- sodium fluoride (18F)
- l-epigallocatechin
- corn
- bupivacaine
- zinc
- ferric carboxymaltose
- +23 more
Organizations
Organization Involved with Phase 4 Indications (36)
- Sanofi
- Corporacion Parc Tauli
- Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
- University of Illinois
- Temple University
- Lund University
- Mount Carmel Health System
- The Institute of Molecular and Translational Medicine, Czech Republic
- Sundsvall Hospital
- Universidad Autonoma de Madrid
- University of Seville
- Wroclaw Medical University
- University of Valencia
- University of Vigo
- Peking University
- University of California, San Francisco
- University of Copenhagen
- University of Ulm
- Uppsala University
- Badalona Hospital Germans Trias i Pujol
- National Taiwan University
- University of Orense
- Complejo Hospitalario La Mancha Centro
- Orebro University
- Osakidetza
- University of Barcelona
- Universidad Autonoma de Barcelona
- Clinica Universidad de Navarra
- University Hospital Brno
- Linkoping University
- +6 more
Organization Involved with Phase 3 Indications (111)
- Amgen
- Merck KGaA
- Pfizer
- Wyeth
- Novartis
- Bayer
- Braintree Laboratories
- Nanjing NingQi Medicine Science and Technology Co., Ltd.
- Norgine
- Vaccinogen Inc
- Amarin
- Central European Society for Anticancer Drug Research (CESAR)
- National Cancer Institute (NCI)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- National Institute on Aging (NIA)
- United States Army
- University of Roma La Sapienza
- Region Syddanmark
- Robert Roessle Klinik
- Huazhong University of Science and Technology
- University of Pennsylvania
- Baylor University
- Canadian Cancer Trials Group
- Cancer and Leukemia Group B (CALGB)
- Case Western Reserve University
- Centro Oncologico de Excelencia
- Harvard University
- Eastern Cooperative Oncology Group
- ECOG-ACRIN Cancer Research Group
- +81 more
Organization Involved with Phase 2 Indications (119)
- Celgene
- Bristol-Myers Squibb
- Biocompatibles International plc
- Imclone
- Immunomedics
- AstraZeneca
- Merck
- Merck Serono
- Eli Lilly
- MedImmune
- Arca Biopharma, Inc.
- Array BioPharma
- Celsion
- DSM
- GammaCan
- GlobeImmune
- Gradalis, Inc.
- Jubilant Innovation Ltd.
- MolMed S.p.A.
- NantCell, Inc.
- PledPharma AB
- Oncovir, Inc.
- Parexel
- Photocure
- Sirtex Medical
- Synta Pharmaceuticals Corp.
- WntResearch AB
- Agendia
- AlphaVax, Inc.
- Boehringer Ingelheim
- +89 more
Organization Involved with Phase 1 Indications (38)
- AbbVie
- Eisai
- Millennium Pharmaceuticals
- AEterna Zentaris
- Asana BioSciences
- Blueprint Medicines Corporation
- Cancer Insight, LLC
- GlaxoSmithKline
- Qilu Pharmaceutical Co., Ltd.
- Sichuan Huiyang Life Science and Technology Corporation
- Epimmune
- Institut Bergonié
- James Graham Brown Cancer Center
- Northwell Health
- Radboud University
- St. Luke's-Roosevelt Hospital Center
- Thomas Jefferson University
- University of Kentucky
- University of Michigan
- Wake Forest University
- Wayne State University
- West Virginia University
- Yale University
- University of Virginia
- Columbia University
- University of California, Davis
- University of Minnesota
- Loxo Oncology
- Al Azhar University
- North Shore Hospital, New Zealand
- +8 more
Organization Involved with Other Experimental Indications (32)
- DuPont
- Genentech
- Helsinn
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- Vastra Gotaland Region
- Centre Hospitalier Universitaire de Nīmes
- Hillel Yaffe Medical Center
- Kaohsiung Medical University
- King Faisal University
- Northwestern University
- Portuguese Oncology Institute, Coimbra
- Seoul National University
- University of Florence
- University of Palermo
- University of Reading
- University of Zagreb
- Dalian Medical University
- University of Connecticut
- King Faisal Specialist Hospital
- Konkuk University
- University of Sao Paulo
- Free University of Brussels
- Wellcome Trust
- University of Nimes
- Alaska Native Tribal Health Consortium
- Jackson Laboratory
- California Walnut Commission
- Aran Biomedical
- Ghent University
- University of Helsinki
- +2 more